Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00948415 · ClinicalTrials.gov registry record · NA

Evaluation of the Shape Up Rhode Island Campaign Study 5

A NA study, sponsored by The Miriam Hospital.

Completed
Registry status
NA
Development phase
128
Enrollment target

NCT00948415: Completed NA study, sponsored by The Miriam Hospital.

NCT00948415 is a NA study that has completed, run by The Miriam Hospital. The registered enrollment target is 128 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00948415, a NA study, has completed, sponsored by The Miriam Hospital.

COMPLETED
Registry status
NA
Development phase
128 participants
Enrollment target

Study Summary

Obesity is a major health problem that has reached epidemic levels. Efforts are needed to develop cost-effective public health approaches for weight loss and maintenance. One such approach is to develop team-based programs that may motivate people to lose weight and/or increase their physical activity. One such program is entitled Shape-up Rhode Island (SURI). The current trial is investigating whether adding both a behavioral intervention delivered online PLUS automated feedback to self-monitoring would enhance the outcomes of SURI participants.

Interventions

  • BEHAVIORAL Evaluation of the Shape Up RI Campaign

Trial Details

FieldValue
Enrollment Target 128 participants
Start Date 2009-01
Est. Completion 2010-12
Phase NA
The Miriam Hospital

136 total trials

What the finished NCT00948415 record still lists

NCT00948415 is an interventional study that assigns participants to a tested intervention. The registered 128 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).

The record links to 0 conditions, and to 1 intervention - of which Evaluation of the Shape Up RI Campaign is the first listed.

NCT00948415 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00948415 about?

NCT00948415 is a clinical study titled "Evaluation of the Shape Up Rhode Island Campaign Study 5". Obesity is a major health problem that has reached epidemic levels. Efforts are needed to develop cost-effective public health approaches for weight loss and maintenance. One such approach is to develop team-based programs that may motivate people to lose weight and/or increase their physical activi...

What is the current status of trial NCT00948415?

This trial is currently completed. It is a NA study. The enrollment target is 128 participants. The study started on 2009-01. Estimated completion is 2010-12.

What interventions are being tested in trial NCT00948415?

The interventions under investigation include: Evaluation of the Shape Up RI Campaign (BEHAVIORAL).

Who is sponsoring clinical trial NCT00948415?

This trial is sponsored by The Miriam Hospital, which has 136 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00948415's enrollment target sits among peer trials

128 744th of 2000 higher than 1,252 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02870738 · 128 participants · Phase 2

    Bladder Directed vs. Pelvic Floor Therapy in IC/BPS

  • NCT03294460 · 128 participants · Phase 1

    Nicotinic Receptor Genetic Variation and Alcohol Reward

  • NCT04149977 · 128 participants · NA

    Blood Flow Restriction Therapy in Lower Limb Extensor Injuries

  • NCT04373057 · 128 participants · Phase 1

    Prebiotic Galacto-oligosaccharide and Acute GVHD

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00948415, the US trial registry maintained by the National Library of Medicine. NCT00948415 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.